CMC documentation for IND and IMPD submissions

ANDA compilation

Risk assessment reports: Residual Solvents, Elemental Impurities, Nitrosamines

Response strategies and write-up for FDA deficiencies

Assessment of post approval changes and implementation (SUPAC)

US Agent services for FDA filings